PPD extract induces the maturation of human monocyte-derived dendritic cells

Immunopharmacology and Immunotoxicology

Volumn 30, Issue 1, 2008, Pages 91-104

  Bagheri, Kambiz ^a,b   Delirezh, Nowruz ^c   Moazzeni, Seyed Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c URMIA UNIVERSITY   (Iran)

Author keywords

Dendritic cells; Immunotherapy; Maturation; PPD; TNF

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CELL STRUCTURE; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BETA-GLUCANS; CELL DIFFERENTIATION; DENDRITIC CELLS; ENDOTOXINS; HUMANS; IMMUNOTHERAPY; MONOCYTES; TUBERCULIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749179280     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970701812654     Document Type: Article

References (47)

1. Adams, S.; O'Neill, D.W.; Bhardwaj, N. Recent advances in dendritic cell biology. J. Clin. Immunol. 2005, 25 (3), 177-188.
2. Granucci, F.; Foti, M.; Ricciardi-Castagnoli, P. Dendritic cell biology. Adv. Immunol. 2005, 88, 193-233.
3. Banchereau, J.; Briere, F.; Caux, C.; Davoust, J.; Lebecque, S.; Liu, Y.J.; Pulendran, B.; Palucka, K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18, 767-811.
4. Gatti, E.; Pierre, P. Understanding the cell biology of antigen presentation: the dendritic cell contribution. Curr. Opin. Cell Biol. 2003, 15 (4), 468-473.
5. Brunner, C.; Seiderer, J.; Schlamp, A.; Bidlingmaier, M.; Eigler, A.; Haimerl, W.; Lehr, H.A.; Krieg, A.M.; Hartmann, G.; Endres, S. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J. Immunol. 2000, 165 (11), 6278-6286.
6. Wurtzen, P.A.; Nissen, M.H.; Claesson, M.H. Maturation of dendritic cells by recombinant human CD40L-trimer leads to a homogeneous cell population with enhanced surface marker expression and increased cytokine production. Scand. J. Immunol. 2001, 53 (6), 579-587.
7. Hart, D.N. Dendritic cell biology evolves into clinical application. Lancet. 2005, 365 (9454), 102-104.
8. Proudfoot, O.; Pouniotis, D.; Sheng, K.C.; Loveland, B.E.; Pietersz, G.A.; Dendritic cell vaccination. Expert Rev. Vaccines. 2007, 6 (4), 617-633.
9. Chapuis, F.; Rosenzwajg, M.; Yagello, M.; Ekman, M.; Biberfeld, P.; Gluckman, J.C. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 1997, 27 (2), 431-441.
10. Decker, W.K.; Xing, D.; Shpall, E.J. Dendritic cell immunotherapy for the treatment of neoplastic disease. Biol. Blood Marrow Transplant. 2006, 12 (2), 113-125.
11. Sallusto, F.; Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179 (4), 1109-1118.
12. Canque, B.; Camus, S.; Yagello, M.; Gluckman, J.C. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro. J. Leukoc. Biol. 1998, 64 (2), 235-244.
13. Granucci, F.; Ferrero, E.; Foti, M.; Aggujaro, D.; Vettoretto, K.; Ricciardi-Castagnoli, P. Early events in dendritic cell maturation induced by LPS. Microbes Infect. 1999, 1 (13), 1079-1084.
14. Kobayashi, T.; Walsh, P.T.; Walsh, M.C.; Speirs, K.M.; Chiffoleau, E.; King C.G.; Hancock, W.W.; Caamano, J.H.; Hunter, C.A.; Scott, P.; Turka, L.A.; Choi, Y. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 2003, 19 (3), 353-363.
15. Morel, Y.; Truneh, A.; Sweet, R.W.; Olive, D.; Costello, R.T. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 2001, 167 (5), 2479-2486.
16. Tuyaerts, S.; Aerts, J.L.; Corthals, J.; Neyns, B.; Heirman, C.; Breckpot, K.; Thielemans, K.; Bonehill, A. Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol. Immunother. 2007, 56 (10), 1513-1537.
17. Sharbaugh, R.J. Administering and interpreting the PPD tuberculin skin test. Home Care Provid. 1998, 3 (3), 141-143.
18. Landi, S.; Held, H.R. Preparation and characterization of a large batch of tuberculin purified protein derivate (PPD-CT68). Ann. Sclavo. 1980, 22 (6), 899-907.
19. Pais, T.F.; Silva, R.A.; Smedegaard, B.; Appelberg, R.; Andersen, P. Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection. Immunology 1998, 95 (1), 69-75.
20. Henderson, R.A.; Watkins, S.C.; Flynn, J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 1997, 159 (2), 635-643.
21. Thurnher, M.; Ramoner, R.; Gastl, G.; Radmayr, C.; Bock, G. Herold, M.; Klocker, H.; Bartsch, G. Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells. Int. J. Cancer 1997, 70 (1), 128-134.
22. Kim, K.D.; Lee, H.G.; Kim, J.K.; Park, S.N.; Choe, I.S.; Choe, Y.K.; Kim, S.J.; Lee, E.; Lim, J.S. Enhanced antigen-presenting activity and tumour necrosis factor-alpha-independent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette-Guerin. Immunology 1999, 97 (4), 626-633.
23. Tsuji, S.; Matsumoto, M.; Takeuchi, O.; Akira, S.; Azuma, I.; Hayashi, A.; Toyoshima, K.; Seya, T. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect. Immun. 2000, 68 (12), 6883-6890.
24. Cheadle, E.J.; Selby, P.J.; Jackson, A.M. Mycobacterium bovis bacillus Calmette-Guerin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanism. Immunology. 2003, 108 (1), 79-88.
25. Ramoner, R.; Rieser, C.; Herold, M.; Klocker, H.; Bartsch, G.; Stenzl, A.; Thurnher, M. Activation of human dendritic cells by bacillus Calmette-Guerin. J. Urol. 1998, 159 (5), 1488-1492.
26. Harboe, M. Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis. Am. Rev. Respir. Dis. 1981, 124 (1), 80-87.
27. Kitaura, H.; Kinomoto, M.; Yamada, T. Ribosomal protein L7 included in tuberculin purified protein derivative (PPD) is a major heat-resistant protein inducing strong delayed-type hypersensitivity. Scand. J. Immunol. 1999, 50 (6), 580-587.
28. Salvetti, M.; Ristori, G.; Buttinelli, C.; Fiori, P.; Falcone, M.; Britton, W.; Adams, E.; Paone, G.; Grasso, M.G.; Pozzilli, C. The immune response to mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J. Neuroimmunol. 1996, 65 (2), 143-153.
29. Mustafa, A.S.; Lundin, K.E.; Meloen, R.H.; Shinnick, T.M.; Oftung, F. Identification of promiscuous epitopes from the Mycobacterial 65-kilodalton heat shock protein recognized by human CD4(+) T cells of the Mycobacterium leprae memory repertoire. Infect. Immun. 1999, 67 (11), 5683-5689.
30. Flohe, S.B.; Bruggemann, J.; Lendemans, S.; Nikulina, M.; Meierhoff, G.; Flohe, S.; Kolb, H. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J. Immunol. 2003, 170 (5), 2340-2348.
31. Bethke, K.; Staib, F.; Distler, M.; Schmitt, U.; Jonuleit, H.; Flohe, S.; Kolb, H. Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60. J. Immunol. 2002, 169 (11), 6141-6148.
32. Jung, S.B.; Song, C.H.; Yang, C.S.; Kim, S.Y.; Lee, K.S.; Shin, A.R.; Lee, J.S.; Nam, H.S.; Kim, H.J.; Park, J.K.; Paik, T.H.; Jo, E.K. Role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in the secretion of tumor necrosis factor-alpha and interleukin-10 by the PPD antigen of Mycobacterium tuberculosis. J. Clin. Immunol. 2005, 25 (5), 482-490.
33. Peetermans, W.E.; Raats, C.J.; van Furth, R.; Langermans, J.A. Mycobacterial 65-kilodalton heat shock protein induces tumor necrosis factor alpha and interleukin 6, reactive nitrogen intermediates, and toxoplasmastatic activity in murine peritoneal macrophages. Infect. Immun. 1995, 63 (9), 3454-3458.
34. Kadowaki, N.; Ho, S.; Antonenko, S.; Malefyt, R.W.; Kastelein, R.A.; Bazan, F.; Liu, Y. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001, 194 (6), 863-869.
35. Werling, D.; Hope, J.C.; Howard, C.J.; Jungi, T.W. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunol. 2004, 111 (1), 41-52.
36. Agrawal, S.; Agrawal, A.; Doughty, B.; Gerwitz, A.; Blenis, J.; Van Dyke, T.; Pulendran, B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 2003, 171 (10), 4984-4989.
37. Watts, C.; Zaru, R.; Prescott, A.R.; Wallin, R.P.; West, M.A. Proximal effects of Toll-like receptor activation in dendritic cells. Curr. Opin. Immunol. 2007, 19 (1), 73-78.
38. Uehori, J.; Matsumoto, M.; Tsuji, S.; Akazawa, T.; Takeuchi. O.; Akira, S.; Kawata, T.; Azuma, I.; Toyoshima, K.; Seya, T. Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan. Infect. Immun. 2003, 71 (8), 4238-4249.
39. Bulut, Y.; Michelsen, K.S.; Hayrapetian, L.; Naiki, Y.; Spallek, R.; Singh, M.; Arditi, M. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J. Biol. Chem. 2005, 280 (22), 20961-20967.
40. Fricke, I.; Mitchell, D.; Mittelstädt, J.; Lehan, N.; Heine, H.; Goldmann, T.; Böhle, A.; Brandau, S. Mycobacteria induce IFN-gamma production in human dendritic cells via triggering of TLR2. J. Immunol. 2006, 176 (9), 5173-5182.
41. Takeda, K.; Akira, K. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17 (1), 1-14.
42. Bausinger, H.; Lipsker, D.; Ziylan, U.; Manie, S.; Briand, J.P.; Cazenave, J.P.; Muller, S.; Haeuw, J.F.; Ravanat, C.; de la Salle, H.; Hanau, D. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 2002, 32 (12), 3708-3713.
43. Nersting, J.; Svenson, M.; Andersen, V.; Bendtzen, K. Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alpha. Immunol. Lett. 2003, 89 (1), 59-65.
44. Cooper, J.F.; Weary, M.E.; Jordan, F.T. The impact of non-endotoxin LAL-reactive materials on Limulus amebocyte lysate analyses. PDA J. Pharm. Sci. Technol. 1997, 51 (1), 2-6.
45. Tsuchiya, M.; Takaoka, A.; Tokioka, N.; Matsuura, S. Development of an endotoxin-specific Limulus amebocyte lysate test blocking beta-glucan-mediated pathway by carboxymethylated curdlan and its application. Nippon Saikingaku Zasshi.1990, 45 (6), 903-911.
46. Vassallo, R.; Limper, A.H. Fungal beta-glucan can yield false-positive results with the limulus amebocyte lysate endotoxin assay. Chest 1999, 116 (2), 583-584.
47. Ikemura, K.; Ikegami, K.; Shimazu, T.; Yoshioka, T.; Sugimoto, T. False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J. Clin. Microbiol. 1989, 27 (9), 1965-1968.